3-tert-butoxycarbonyl-7-chloro-6-dimethylaminocarbonylthio-2,3,4,5-tetrahydro-1H-benzo[d]azepine → HCID 66707312, compound
Reaction equation
C(OC([N:8]1[CH2:14][CH2:13][C:12]2[C:15]([S:20][C:21](=O)N(C)C)=[C:16]([Cl:19])[CH:17]=[CH:18][C:11]=2[CH2:10][CH2:9]1)=O)(C)(C)C.BrC[CH2:28][CH2:29][C:30]1[O:34][N:33]=[C:32]([C:35]([CH3:38])([CH3:37])[CH3:36])[N:31]=1>>[ClH:19].[C:35]([C:32]1[N:31]=[C:30]([CH2:29][CH2:28][CH2:21][S:20][C:15]2[C:12]3[CH2:13][CH2:14][NH:8][CH2:9][CH2:10][C:11]=3[CH:18]=[CH:17][C:16]=2[Cl:19])[O:34][N:33]=1)([CH3:38])([CH3:37])[CH3:36]Participants
3
Procedure
Use a method similar to the Example 387, using 3-tert-butoxycarbonyl-7-chloro-6-dimethylcarbamoylthio-2,3,4,5-tetrahydro-1H-benzo[d]azepine and 5-(3-bromopropyl)-3-tert-butyl-[1,2,4]oxadiazole to give, after deprotection using a method similar to the General Procedure 1-4, the title compound as a white solid. MS (APCI+) m/z 380 (M+H)+.
Workup
- customto give
Sources & evidence
- ORD record
- ord-6db5460050ca479cb9979a2fb8fb46ec
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08580780B2
Reaction notes
Loading…